These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1753017)

  • 21. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 22. Left ventricular dysfunction and ventricular arrhythmias: reducing the risk of sudden death.
    Podrid PJ; Fuchs TT
    J Clin Pharmacol; 1991 Nov; 31(11):1096-104. PubMed ID: 1753015
    [No Abstract]   [Full Text] [Related]  

  • 23. Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
    Neri R; Mestroni L; Salvi A; Pandullo C; Camerini F
    Am Heart J; 1987 Mar; 113(3):707-15. PubMed ID: 3825860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone and mortality in CHF and post-MI.
    Zamorski M
    J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
    Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance and management of arrhythmias in the heart failure patient.
    Greene HL
    Clin Cardiol; 1992 Sep; 15 Suppl 1():I13-21. PubMed ID: 1395210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of oral amiodarone in the treatment of ventricular arrhythmias in heart disease.
    Levy S
    Drugs; 1991; 41 Suppl 2():47-53. PubMed ID: 1711968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone and torsades de pointes in patients with advanced heart failure.
    Middlekauff HR; Stevenson WG; Saxon LA; Stevenson LW
    Am J Cardiol; 1995 Sep; 76(7):499-502. PubMed ID: 7653452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year follow-up of 589 patients treated with amiodarone.
    Weinberg BA; Miles WM; Klein LS; Bolander JE; Dusman RE; Stanton MS; Heger JJ; Langefeld C; Zipes DP
    Am Heart J; 1993 Jan; 125(1):109-20. PubMed ID: 8417505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular arrhythmias in heart failure.
    Mitamura H
    Keio J Med; 1996 Mar; 45(1):1-8. PubMed ID: 8882462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).
    Behrens S; Ney G; Fisher SG; Fletcher RD; Franz MR; Singh SN
    Am J Cardiol; 1997 Jul; 80(1):45-8. PubMed ID: 9205018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy.
    Singh SN; Fletcher RD
    Am J Cardiol; 1999 Nov; 84(9A):103R-108R. PubMed ID: 10568668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous amiodarone in the treatment of refractory arrhythmias.
    Alves LE; Rose EP; Cahill TB
    Crit Care Med; 1985 Sep; 13(9):750-2. PubMed ID: 4028770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone in long term prophylaxis.
    Katritsis D; Camm AJ
    Drugs; 1991; 41 Suppl 2():54-66. PubMed ID: 1711969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where to go in risk stratification for sudden cardiac death: Are P values enough?
    Huikuri HV
    Heart Rhythm; 2015 Oct; 12(10):2067-8. PubMed ID: 26164375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.